ImmunoPET in Multiple Myeloma—What? So What? Now What? - Archive ouverte HAL Access content directly
Journal Articles Cancers Year : 2020

ImmunoPET in Multiple Myeloma—What? So What? Now What?

(1, 2) , (1) , (1) , (1, 2) , (1) , (1) , (3) , (3) , (1, 2, 4) , (1, 2) , (1, 4)
1
2
3
4

Abstract

Despite constant progress over the past three decades, multiple myeloma (MM) is still an incurable disease, and the identification of new biomarkers to better select patients and adapt therapy is more relevant than ever. Recently, the introduction of therapeutic monoclonal antibodies (mAbs) (including direct-targeting mAbs and immune checkpoint inhibitors) appears to have changed the paradigm of MM management, emphasizing the opportunity to cure MM patients through an immunotherapeutic approach. In this context, immuno-positron emission tomography (immunoPET), combining the high sensitivity and resolution of a PET camera with the specificity of a radiolabelled mAb, holds the capability to cement this new treatment paradigm for MM patients. It has the potential to non-invasively monitor the distribution of therapeutic antibodies or directly monitor biomarkers on MM cells, and to allow direct observation of potential changes over time and in response to various therapeutic interventions. Tumor response could, in the future, be anticipated more effectively to provide individualized treatment plans tailored to patients according to their unique imaging signatures. This work explores the important role played by immunotherapeutics in the management of MM, and focuses on some of the challenges for this drug class and the significant interest of companion imaging agents such as immunoPET.
Fichier principal
Vignette du fichier
cancers-12-01467-v2.pdf (1.06 Mo) Télécharger le fichier
Origin : Publisher files allowed on an open archive
Loading...

Dates and versions

inserm-02881836 , version 1 (26-06-2020)

Identifiers

Cite

Clément Bailly, Benjamin Chalopin, Sébastien Gouard, Thomas Carlier, Patricia Remaud-Le Saec, et al.. ImmunoPET in Multiple Myeloma—What? So What? Now What?. Cancers, 2020, 12 (6), pp.1467. ⟨10.3390/cancers12061467⟩. ⟨inserm-02881836⟩
44 View
66 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More